MedPath

Shifting the interpretation bias and attention bias with an online training in borderline personality disorder

Phase 2
Conditions
borderline personality disorder
10034726
Registration Number
NL-OMON51684
Lead Sponsor
GGZ Centraal (Amersfoort)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
92
Inclusion Criteria

The patients in the clinical group are in treatment at GGZ Centraal, a mental
health institution. They will be approached through GGZ Centraal. BPD has been
determined in these patients with the SCID-5P. The non-clinical group will be
approached through the SONA-system of Utrecht University. The patients and
healthy individuals will be between 18 and 65 years old.

Exclusion Criteria

Exclusion criteria for participants: Participants should not have any problems
with their vision. In the non-clinical group, participants with a score above
cut-off point on the BSL-23 will be excluded. In the clinical group,
participants with acute psychotic symptoms, a neurological disease or being
under influence of addictive substances will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary outcome measures:<br /><br>- Effectiveness of the IBT: the threshold on the continuum from an angry to<br /><br>happy face on day 1 is compared to the threshold measured on day 7<br /><br>- Effectiveness of the ABT: the mean reaction time for finding the happy face<br /><br>among angry faces within the premeasurement on day 1 is compared to the mean<br /><br>reaction time for finding the happy face among angry faces within the<br /><br>postmeasurement on day 7</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcome measure.<br />- A shift on the questionnaire assessing quality of life between the<br />premeasurement on day 1 and the follow-up measurements on day 7, after one<br />month and after three months.<br />- A shift on the questionnaire mapping perceived social support between the<br />premeasurement on day 1 and the follow-up measurements on day 7, after one<br />month and after three months.</p>
© Copyright 2025. All Rights Reserved by MedPath